home · filing · 0001493152-22-024111
8-K
filed August 26, 2022, 7:59 PM ET
ticker VTSI
CIK 0001085243
leadership
confidence high
sentiment neutral
materiality 0.35
VirTra appoints Danielle Diaz as CFO, replacing Marsha Foxx
VirTra, Inc
Danielle Diaz named CFO effective August 24, 2022; Marsha Foxx terminated as CAO, no disagreement.
Diaz receives $200,000 annual salary plus 15,000 performance-based RSUs vesting over 3 years.
Diaz brings 20+ years financial experience; most recently CFO at Bakersfield Heart Hospital.
Foxx's departure not related to any accounting or policy disagreements with VirTra.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Marsha Foxx
Chief Accounting Officer
Effective 2022-08-24
Filed August 26, 2022, 7:59 PM ET
Also, effective August 24, 2022, Marsha Foxx was terminated as the Chief Accounting Officer of VirTra.
Appointed
Danielle De Rosa-Diaz
Chief Financial Officer
Effective 2022-08-24
Filed August 26, 2022, 7:59 PM ET
Effective August 24, 2022, VirTra appointed Danielle De Rosa-Diaz, 45, as its Chief Financial Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Marsha Foxx was terminated as Chief Accounting Officer at VirTra, Inc.
Action terminated
Role Chief Accounting Officer
Exact text from the filing
Also, effective August 24, 2022, Marsha Foxx was terminated as the Chief Accounting Officer of VirTra.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Danielle De Rosa-Diaz was appointed as Chief Financial Officer at VirTra, Inc.
Action appointed
Role Chief Financial Officer
Exact text from the filing
Effective August 24, 2022, VirTra appointed Danielle De Rosa-Diaz, 45, as its Chief Financial Officer.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-22-024111
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.